BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GNC-077 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of GNC-077\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06755242-2497@assetmemo.bio
DTSTAMP:20261121T005420Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:GNC-077: Phase 1 readout est. (NCT06755242)
DESCRIPTION:GNC-077\, phase 1.\nStudy: A Study of GNC-077 in Patients With 
 Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tum
 ors\nEstimated primary completion: June 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/gnc-077#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT06755242
URL:https://assetmemo.bio/drug/gnc-077#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
